Prevalence of antimicrobial resistance in respiratory tract isolates of Streptococcus pneumoniae: results of a Canadian national surveillance study. The Canadian Respiratory Infection Study Group
- PMID: 10508032
- PMCID: PMC89508
- DOI: 10.1128/AAC.43.10.2504
Prevalence of antimicrobial resistance in respiratory tract isolates of Streptococcus pneumoniae: results of a Canadian national surveillance study. The Canadian Respiratory Infection Study Group
Erratum in
- Antimicrob Agents Chemother 2000 Nov;44(11):3247
Abstract
From October 1997 to November 1998, 1,180 respiratory tract isolates of Streptococcus pneumoniae were collected from 18 medical centers in 9 of the 10 Canadian provinces. Penicillin-intermediate and -resistant isolates occurred at rates of 14.8 and 6.4%, respectively, and these rates varied considerably by geographic region. Trimethoprim-sulfamethoxazole, tetracycline, and macrolide rates of nonsusceptibility were 12.2, 10.6, and 8.0 to 9.3%, respectively. The most potent agents studied were newer fluoroquinolones.
Comment in
-
Assumed versus approved breakpoints.Antimicrob Agents Chemother. 2000 Nov;44(11):3243-5. doi: 10.1128/AAC.44.11.3243-3245.2000. Antimicrob Agents Chemother. 2000. PMID: 11184232 Free PMC article. No abstract available.
References
-
- Doern G V, Brueggemann A, Holley H P, Jr, Rauch A M. Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study. Antimicrob Agents Chemother. 1996;40:1208–1213. - PMC - PubMed
-
- Doern G V, Pfaller M A, Kugler K, Freeman J, Jones R N. Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY antimicrobial surveillance program. Clin Infect Dis. 1998;27:764–770. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
